Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, July 22, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Advancing High-Content Analysis for Cancer Applications
Tuesday, April 08, 2014
A new high-content screening software platform enables cancer researchers to uncover more about basic and advanced cellular function to accelerate cell-based research.

InSphero to Distribute Dainippon Screen Imager for Rapid Profiling of 3D Microtissues
Tuesday, April 08, 2014
The Cell'iMager, to be marketed in the US and Europe, simplifies growth and morphological profiling of 3D microtissues.

Horizon Discovery Launches New Gene Editing Tools and Services
Monday, April 07, 2014
The comprehensive product and service solution enables easier, robust implementation of gene editing experiments in customer’s hands.

QIAGEN Expands Product Portfolio for NGS and Cancer Research
Saturday, April 05, 2014
New innovative product launches at AACR Annual Meeting add to broad portfolio of NGS solutions.

New Application of TAP’s Automated Cell Culture System at AACR
Saturday, April 05, 2014
Offers rapid production and consistent quality of NCI 60 cancer cell line panel.

Illumina Expands Product Portfolio
Thursday, April 03, 2014
End-to-end genomics solutions will transform the future of oncology.

PGDx Raises $2.8 Million and Launches its METDetect™ Assay
Thursday, April 03, 2014
First-in-class CLIA assay for detection of tumor-specific gene amplifications using circulating cell-free DNA.

Cancer Genetics Expands BioDiscovery's Nexus Copy Number Platform
Thursday, April 03, 2014
Expansion to identify novel biomarkers predictive of cancer outcomes.

Physiologically Relevant Cell Culture Handbook
Tuesday, April 01, 2014
48-page handbook is also a resource for neuroscience, drug discovery and regenerative medicine applications.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 640
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv